Belén Garijo

Garijo leads Merck KGaA, a global drug and sciences company with $23 billion in annual sales and a history that dates back to 1668—not to be confused with U.S. pharma giant Merck. Its top-selling products include oncology and multiple sclerosis drugs. But Merck KGaA’s biggest and fastest-growing business is its life sciences division, which serves the broader sector, making specialty products like the lipids used in mRNA COVID vaccines.